Literature DB >> 23504533

A Van Leusen deprotection-cyclization strategy as a fast entry into two imidazoquinoxaline families.

Fabio De Moliner1, Christopher Hulme.   

Abstract

A concise synthesis of two pharmacologically relevant classes of molecules possessing the imidazoquinoxaline core is reported. The protocol involves use of 1,2-phenylenediamines and glyoxylic acid derivatives, namely ethyl glyoxylate or benzylglyoxamide, along with tosylmethylisocyanides in a microwave-assisted Van Leusen three-component condensation. Subsequent unmasking (Boc removal) of an internal amino-nucleophile promotes deprotection and cyclization that take place either spontaneously in a one-pot fashion to give 8 or upon acidic treatment under microwave irradiation after isolation of the imidazole intermediate to give 11. Of note, a tricyclic framework is hence assembled by means of a rapid and straightforward method with a high bond-forming efficiency.

Entities:  

Keywords:  Heterocycles; Imidazoquinoxalines; Multicomponent reactions; TOSMICs

Year:  2012        PMID: 23504533      PMCID: PMC3596093          DOI: 10.1016/j.tetlet.2012.08.072

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  25 in total

1.  Novel multicomponent reaction for the combinatorial synthesis of 2-imidazolines.

Authors:  Robin S Bon; Chongen Hong; Marinus J Bouma; Rob F Schmitz; Frans J J de Kanter; Martin Lutz; Anthony L Spek; Romano V A Orru
Journal:  Org Lett       Date:  2003-10-02       Impact factor: 6.005

2.  Synthesis of peptidomimetics, δ- and ε-lactam tetrazoles.

Authors:  Steven Gunawan; Kristen Keck; Alex Laetsch; Christopher Hulme
Journal:  Mol Divers       Date:  2012-05-24       Impact factor: 2.943

3.  One-pot synthesis of substituted 2,2'-bipyrroles. A straightforward route to aryl porphycenes.

Authors:  David Sánchez-García; José I Borrell; Santi Nonell
Journal:  Org Lett       Date:  2009-01-01       Impact factor: 6.005

4.  Facile and rapid route for the synthesis of novel conformationally constrained norstatine analogs via PADAM-cyclization methodology.

Authors:  Arthur Y Shaw; Federico Medda; Christopher Hulme
Journal:  Tetrahedron Lett       Date:  2012-03-14       Impact factor: 2.415

5.  Concise one-pot preparation of unique bis-pyrrolidinone tetrazoles.

Authors:  Steven Gunawan; Joachim Petit; Christopher Hulme
Journal:  ACS Comb Sci       Date:  2012-02-15       Impact factor: 3.784

6.  Applications of multicomponent reactions to the synthesis of diverse heterocyclic scaffolds.

Authors:  James D Sunderhaus; Stephen F Martin
Journal:  Chemistry       Date:  2009       Impact factor: 5.236

7.  In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives.

Authors:  Georges Moarbess; Carine Deleuze-Masquefa; Vanessa Bonnard; Stéphanie Gayraud-Paniagua; Jean-Rémi Vidal; Françoise Bressolle; Frédéric Pinguet; Pierre-Antoine Bonnet
Journal:  Bioorg Med Chem       Date:  2008-05-10       Impact factor: 3.641

8.  Nucleophilic addition to electron-rich heteroaromatics: dearomatizing anionic cyclizations of pyrrolecarboxamides.

Authors:  Jonathan Clayden; Rachel Turnbull; Ivan Pinto
Journal:  Org Lett       Date:  2004-02-19       Impact factor: 6.005

9.  A resource-efficient and highly flexible procedure for a three-component synthesis of 2-imidazolines.

Authors:  Niels Elders; Rob F Schmitz; Frans J J de Kanter; Eelco Ruijter; Marinus B Groen; Romano V A Orru
Journal:  J Org Chem       Date:  2007-07-12       Impact factor: 4.354

Review 10.  Emerging molecular diversity from the intra-molecular Ugi reaction: iterative efficiency in medicinal chemistry.

Authors:  Christopher Hulme; Justin Dietrich
Journal:  Mol Divers       Date:  2009-02-11       Impact factor: 3.364

View more
  1 in total

1.  Aldol reactions in multicomponent reaction based domino pathways: a multipurpose enabling tool in heterocyclic chemistry.

Authors:  Zhigang Xu; Fabio De Moliner; Alexandra P Cappelli; Christopher Hulme
Journal:  Org Lett       Date:  2013-05-29       Impact factor: 6.005

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.